Asthma control: Where do we fail?

European Respiratory Journal

Volumn 16, Issue 5, 2000, Pages 797-798

  Kips, J C ^a   Pauwels, R A ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; STEROID;

ASTHMA; COST EFFECTIVENESS ANALYSIS; EDITORIAL; HEALTH CARE UTILIZATION; HUMAN; LUNG FUNCTION; PRACTICE GUIDELINE; PRIORITY JOURNAL;

ASTHMA; TREATMENT FAILURE;

EID: 0034526452     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.00.16579700     Document Type: Editorial

References (25)

1. Clinical management of asthma in 1999: The Asthma Insights and Reality in Europe (AIRE) study
2. Use of inhaled medications and urgent care services. Study of Canadian asthma patients
3. Asthma survey demonstrates that the goals of the NHLBI have not been accomplished
4. The costs of asthma
5. Association of asthma control with health care utilization and quality of life
6. Underdiagnosis of asthma: Is the doctor or the patient to blame? The DIMCA project
7. Development and validation of a questionnaire to measure asthma control
8. Measurement of chronic disease by practitioners and patients: Are we teaching the wrong things?
9. Evaluating an educational intervention to improve the treatment of asthma in four European countries. Drug Education Group
10. Long-term effects of asthma education for physicians on patient satisfaction and use of health services
11. Perception of the role and potential side effects of inhaled corticosteroids among asthmatic patients
12. Medication, chronic illness and identity: The perspective of people with asthma
13. Poverty, race, and medication use are correlates of asthma hospitalization rates
14. Cost effectiveness of inhaled corticosteroid plus bronchodilator therapy versus bronchodilator monotherapy in children with asthma
15. Low-dose inhaled corticosteroids and the prevention of death from asthma
16. Effect of long-term treatment with inhaled budesonide on adult height in children with asthma
17. Undertreatment in a nonselected population of adult patients with asthma
18. Morbidity from asthma in relation to regular treatment: A community based study
19. How does patient education and self-management among asthmatics and patients with chronic obstructive pulmonary disease affect medication?
20. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid
21. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids
22. Effect of inhaled formoterol and budesonide on exacerbations of asthma
23. Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: A randomized, double-blind, placebo-controlled trial
24. Combined salmeterol 50 microg and fluticasone propionate 250 microg in the diskus device for the treatment of asthma